136 related articles for article (PubMed ID: 14531077)
1. Polyethylene-glycolated immunoliposomes specific for astrocytes.
Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Blinov DV; Dmitrieva TB
Dokl Biochem Biophys; 2003; 391():236-9. PubMed ID: 14531077
[No Abstract] [Full Text] [Related]
2. Building and characterizing antibody-targeted lipidic nanotherapeutics.
Kirpotin DB; Noble CO; Hayes ME; Huang Z; Kornaga T; Zhou Y; Nielsen UB; Marks JD; Drummond DC
Methods Enzymol; 2012; 502():139-66. PubMed ID: 22208985
[TBL] [Abstract][Full Text] [Related]
3. [Production and characteristics of PEGylated immunoliposome transport vectors specific for neural tissue astrocytes].
Chekhonin VP; Zhirkov IuA; Gurina OI; Lebedev SV; Dmitrieva TB; Semenova AV; Iaglova TV; Riabinina AE
Biomed Khim; 2005; 51(3):276-86. PubMed ID: 16104390
[TBL] [Abstract][Full Text] [Related]
4. Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.
Manjappa AS; Chaudhari KR; Venkataraju MP; Dantuluri P; Nanda B; Sidda C; Sawant KK; Murthy RS
J Control Release; 2011 Feb; 150(1):2-22. PubMed ID: 21095210
[TBL] [Abstract][Full Text] [Related]
5. Targetability of novel immunoliposomes prepared by a new antibody conjugation technique.
Bendas G; Krause A; Bakowsky U; Vogel J; Rothe U
Int J Pharm; 1999 Apr; 181(1):79-93. PubMed ID: 10370205
[TBL] [Abstract][Full Text] [Related]
6. Preparation and targeted delivery of immunoliposomes bearing poly(ethylene glycol)-coupled humanized anti-hepatoma disulfide-stabilized Fv (hdsFv25) in vitro.
Hu H; Chen D; Liu Y; Deng Y; Yang S; Qiao M; Zhao J; Zhao X
Pharmazie; 2006 Aug; 61(8):685-8. PubMed ID: 16964711
[TBL] [Abstract][Full Text] [Related]
7. Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells.
Li T; Amari T; Semba K; Yamamoto T; Takeoka S
Nanomedicine; 2017 Apr; 13(3):1219-1227. PubMed ID: 27965166
[TBL] [Abstract][Full Text] [Related]
8. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
[TBL] [Abstract][Full Text] [Related]
9. A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs).
Skjørringe T; Gjetting T; Jensen TG
J Control Release; 2009 Oct; 139(2):140-5. PubMed ID: 19545595
[TBL] [Abstract][Full Text] [Related]
10. PEG-treated immunoliposomes specific for the Schwann cells of neural tissue.
Chekhonin VP; Gurina OI; Lokhonina AV; Ryabinina AE; Maksimova MA; Semenova AV; Shvets VI
Dokl Biochem Biophys; 2007; 417():343-5. PubMed ID: 18274456
[No Abstract] [Full Text] [Related]
11. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells.
Simard P; Leroux JC
Int J Pharm; 2009 Nov; 381(2):86-96. PubMed ID: 19446624
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of liposomal drug carrier systems in cancer chemotherapy.
Gabizon A
J Liposome Res; 2003 Feb; 13(1):17-20. PubMed ID: 12725722
[No Abstract] [Full Text] [Related]
13. Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents.
Torchilin VP
Immunomethods; 1994 Jun; 4(3):244-58. PubMed ID: 7820455
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipid composition on incorporation of trastuzumab-PEG-lipid into nanoliposomes by post-insertion method: physicochemical and cellular characterization.
Golkar N; Tamaddon AM; Samani SM
J Liposome Res; 2016; 26(2):113-25. PubMed ID: 26023889
[TBL] [Abstract][Full Text] [Related]
15. PEGylated immunoliposomes directed against brain astrocytes.
Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Dmitriyeva TB
Drug Deliv; 2005; 12(1):1-6. PubMed ID: 15801714
[TBL] [Abstract][Full Text] [Related]
16. Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better.
Li H; Di J; Peng B; Xu Y; Zhang N
Pharm Res; 2021 Sep; 38(9):1593-1600. PubMed ID: 34463936
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Immunoliposomes by Direct Coupling of Antibodies Based on a Thioether Bond.
Petrilli R; Eloy JO; Lee RJ; Lopez RFV
Methods Mol Biol; 2018; 1674():229-237. PubMed ID: 28921442
[TBL] [Abstract][Full Text] [Related]
18. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
Pan X; Lee RJ
Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
[TBL] [Abstract][Full Text] [Related]
19. Immunoliposomes: A review on functionalization strategies and targets for drug delivery.
Eloy JO; Petrilli R; Trevizan LNF; Chorilli M
Colloids Surf B Biointerfaces; 2017 Nov; 159():454-467. PubMed ID: 28837895
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.
Eloy JO; Petrilli R; Brueggemeier RW; Marchetti JM; Lee RJ
Anticancer Agents Med Chem; 2017; 17(1):48-56. PubMed ID: 27225450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
